Stockscreener 앱 받기
1.11
1.83%
0.02
전일 마감가:
$1.09
열려 있는:
$1.11
하루 거래량:
354.73K
Relative Volume:
0.60
시가총액:
$107.86M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.7903
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
+0.91%
1개월 성능:
-2.63%
6개월 성능:
-12.60%
1년 성능:
-7.50%
1일 변동 폭
$1.09
$1.1451
1주일 범위
$1.06
$1.18
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.11 | 105.91M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Will Hyperfine Inc. stock continue dividend increasesQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
EV Market: Is Hyperfine Inc part of any major indexJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Hyperfine’s HYPR Stock: Can Portable MRI’s Under-the-Radar Disruptor Turn Volatility Into a Brea - AD HOC NEWS
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Increases By 46.4% - MarketBeat
Analyst Calls: Does Hyperfine Inc have a sustainable dividendBond Market & Low Volatility Stock Recommendations - baoquankhu1.vn
Hyperfine’s portable MRI shows promise in detecting small strokes By Investing.com - Investing.com Australia
Hyperfine’s portable MRI shows promise in detecting small strokes - Investing.com
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System’s Enhanced Stroke Detection Capabilities - The AI Journal
Quarterly Earnings: Is Hyperfine Inc stock showing strong momentum2025 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 87% over the last five years - Yahoo Finance
Hyperfine’s portable brain MRI shows high concordance with standard MRI By Investing.com - Investing.com Nigeria
Hyperfine (HYPR) Receives a Buy from Lake Street - The Globe and Mail
Study Shows Economic Benefits of Swoop System Use in Acute Hospital Care - Medical Product Outsourcing
Quarterly Risk: Is Hyperfine Inc affected by consumer sentimentOptions Play & Real-Time Sentiment Analysis - baoquankhu1.vn
Growth Review: Is Hyperfine Inc gaining market shareTrade Performance Summary & Low Risk High Win Rate Picks - baoquankhu1.vn
Institution Moves: How does ALEX perform in inflationary periodsJuly 2025 Selloffs & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics - 01net
Insider Trends: Is Hyperfine Inc affected by consumer sentimentMarket Activity Recap & Fast Gain Stock Tips - baoquankhu1.vn
Hyperfine’s portable brain MRI shows high concordance with standard MRI - Investing.com
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Up 29.5% in December - MarketBeat
Market Trends: Is KRRO currently under institutional pressure2025 Analyst Calls & Smart Investment Allocation Tips - baoquankhu1.vn
Energy Moves: How does Hyperfine Inc score in quality rankings2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hyperfine Enrolls 1st Patient in Contrast PMR Study - Medical Product Outsourcing
Hyperfine begins clinical study for contrast-enhanced portable MRI By Investing.com - Investing.com Nigeria
Hyperfine Enrolls First Patient in Contrast-Enhanced Portable MRI Study - marketscreener.com
Hyperfine, Inc. Announces Enrollment of First Patient in Study to Expand Intended Use of Swoop System with Contrast Agents - marketscreener.com
Hyperfine begins clinical study for contrast-enhanced portable MRI - Investing.com
Hyperfine announces enrollment of first patient in study to expand intended use of the Swoop® system with contrast agents - marketscreener.com
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - The AI Journal
Revenues Tell The Story For Hyperfine, Inc. (NASDAQ:HYPR) As Its Stock Soars 34% - simplywall.st
Treasury Yields: Is Hyperfine Inc stock showing strong momentumJuly 2025 Volume & Fast Moving Stock Watchlists - baoquankhu1.vn
Hyperfine announces workforce reduction to streamline operations - MSN
Indian Regulators Approve Hyperfine’s Swoop System - Medical Product Outsourcing
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 - Investing.com Canada
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 By Investing.com - Investing.com South Africa
Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M - TipRanks
Hyperfine Announces Strong Preliminary Q4 2025 Revenue Growth - TipRanks
Health tech firm Hyperfine prelim Q4 revenue rises 127% on Swoop system adoption - TradingView — Track All Markets
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Published on: 2026-01-10 20:32:17 - Улправда
Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence - MSN
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - FinancialContent
Can Hyperfine Inc. stock maintain growth trajectoryCEO Change & Safe Entry Trade Signal Reports - ulpravda.ru
Is Hyperfine Inc. stock attractive for long term wealth buildingWeekly Trade Review & Daily Entry Point Trade Alerts - ulpravda.ru
Is Hyperfine Inc. stock supported by strong cash flowsWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - ulpravda.ru
Hyperfine (HYPR) Price Target Increased by 20.00% to 1.73 - MSN
How Hyperfine Inc. stock valuations compare to rivalsAutomated Trading Signals & Analyze Your Portfolio Risk in Seconds - Улправда
Can Hyperfine Inc. stock hit analyst price targets2026 world cup usa national team quarterfinals goalkeepers high defensive line odds analysis insights - ulpravda.ru
Star TribuneHyperfine, Inc.Class A Common Stock (Nasdaq:HYPR) Price Chart - FinancialContent
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):